簡介

本頁面提供了有關 Scott A Holmes 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Scott A Holmes已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:KERX / Keryx Biopharmaceuticals, Inc. Chief Financial Officer 0
US:US00163UAD81 / AMAG Pharmaceuticals, Inc. Bond SVP, Finance and Treasurer 11,500
如何解讀這些圖表

以下圖表顯示了在Scott A Holmes進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

歷史內部人交易

該表格顯示了由 Scott A Holmes 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2018-12-13 2018-12-12 4 KERX KERYX BIOPHARMACEUTICALS INC
Stock Option
D - Sale to Issuer -902,500 0 -100.00
2018-12-13 2018-12-12 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -162,956 0 -100.00
2018-11-16 2018-11-15 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock
S - Sale -1,155 162,956 -0.70 2.77 -3,199 451,388
2018-10-30 2018-10-29 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock
S - Sale -1,254 164,111 -0.76 3.07 -3,850 503,821
2018-08-16 2018-08-15 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock
S - Sale -1,185 165,365 -0.71 3.04 -3,602 502,710
2018-07-31 2018-07-30 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock
S - Sale -2,354 166,550 -1.39 3.86 -9,086 642,883
2018-05-16 2018-05-15 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock
S - Sale -1,158 168,904 -0.68 5.69 -6,589 961,064
2018-05-01 2018-04-30 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock
S - Sale -2,407 170,062 -1.40 4.67 -11,241 794,190
2018-03-22 2018-03-20 4 KERX KERYX BIOPHARMACEUTICALS INC
Stock Options (right to buy)
A - Award 82,500 82,500
2018-03-22 2018-03-20 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock
A - Award 41,250 172,469 31.44
2018-02-16 2018-02-15 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock
S - Sale -5,651 131,219 -4.13 4.81 -27,181 631,163
2018-01-31 2018-01-29 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock
S - Sale -2,830 136,870 -2.03 4.81 -13,612 658,345
2017-10-31 2017-10-30 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock
S - Sale -2,582 139,700 -1.81 6.03 -15,569 842,391
2017-08-01 2017-07-31 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock
S - Sale -1,445 142,282 -1.01 7.14 -10,317 1,015,893
2017-07-31 2017-07-28 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock
S - Sale -1,236 143,727 -0.85 6.96 -8,603 1,000,340
2017-05-03 2017-05-01 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock
S - Sale -1,441 144,963 -0.98 5.97 -8,603 865,429
2017-05-01 2017-04-28 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock
S - Sale -1,219 146,404 -0.83 5.89 -7,180 862,320
2017-03-15 2017-02-14 4 KERX KERYX BIOPHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
A - Award 97,500 97,500
2017-03-15 2017-02-14 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock
A - Award 48,750 147,623 49.31
2017-01-31 2017-01-30 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock
S - Sale -8,447 98,873 -7.87 4.65 -39,279 459,759
2016-10-31 2016-10-28 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock
S - Sale -1,237 107,320 -1.14 4.44 -5,492 476,501
2016-08-02 2016-07-29 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock
S - Sale -4,935 108,557 -4.35 7.36 -36,322 798,980
2016-02-01 2016-01-28 4 KERX KERYX BIOPHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
A - Award 107,500 107,500
2016-02-01 2016-01-28 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock
A - Award 53,750 113,492 89.97
2015-11-05 2015-11-04 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 1,328 59,742 2.27 5.40 7,171 322,607
2015-11-05 2015-11-03 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 3,672 58,414 6.71 5.30 19,458 309,536
2015-08-24 2015-08-21 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 5,000 54,742 10.05 5.72 28,590 313,015
2015-08-03 2015-07-31 4 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock
S - Sale -2,758 49,742 -5.25 7.87 -21,705 391,470
2015-08-03 3 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock (Restricted)
60,000
2015-08-03 3 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock (Restricted)
97,500
2015-08-03 3 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock (Restricted)
60,000
2015-08-03 3 KERX KERYX BIOPHARMACEUTICALS INC
Common Stock (Restricted)
97,500
2015-06-17 2015-06-15 4 AMAG AMAG PHARMACEUTICALS INC.
Stock Option (Right to Buy)
M - Exercise X 3,500 11,500 43.75
2015-06-17 2015-06-15 4 AMAG AMAG PHARMACEUTICALS INC.
Stock Option (Right to Buy)
M - Exercise X 2,734 14,375 23.49
2015-06-17 2015-06-15 4 AMAG AMAG PHARMACEUTICALS INC.
Common Stock
S - Sale X -6,234 51,958 -10.71 66.63 -415,371 3,461,962
2015-06-17 2015-06-15 4 AMAG AMAG PHARMACEUTICALS INC.
Common Stock
M - Exercise X 3,500 58,192 6.40 16.55 57,925 963,078
2015-06-17 2015-06-15 4 AMAG AMAG PHARMACEUTICALS INC.
Common Stock
M - Exercise X 2,734 54,692 5.26 14.89 40,709 814,364
2015-06-17 2015-06-15 4 AMAG AMAG PHARMACEUTICALS INC.
Common Stock
S - Sale X -1,346 51,958 -2.53 66.63 -89,684 3,461,962
2015-06-05 2015-06-03 4 AMAG AMAG PHARMACEUTICALS INC.
Common Stock
S - Sale -22,516 30,788 -42.24 68.88 -1,550,902 2,120,677
2015-03-05 2015-03-03 4 AMAG AMAG PHARMACEUTICALS INC.
Common Stock
F - Taxes -533 53,304 -0.99 49.70 -26,490 2,649,209
2015-02-27 2015-02-26 4 AMAG AMAG PHARMACEUTICALS INC.
Stock Option (Right to Buy)
A - Award 10,000 10,000
2015-02-27 2015-02-26 4 AMAG AMAG PHARMACEUTICALS INC.
Common Stock
A - Award 5,000 53,837 10.24
2014-12-18 2014-12-17 4 AMAG AMAG PHARMACEUTICALS INC.
Common Stock
F - Taxes -859 48,837 -1.73 40.49 -34,781 1,977,410
2014-08-21 2014-08-19 4 AMAG AMAG PHARMACEUTICALS INC.
Common Stock
A - Award 15,000 49,696 43.23
2014-08-21 2014-08-19 4 AMAG AMAG PHARMACEUTICALS INC.
Common Stock
A - Award 5,000 34,696 16.84
2014-06-11 2014-06-11 4 AMAG AMAG PHARMACEUTICALS INC.
Stock Option (Right to Buy)
A - Award 30,000 30,000
2014-06-11 2014-06-11 4 AMAG AMAG PHARMACEUTICALS INC.
Common Stock
A - Award 15,000 29,696 102.07
2014-02-28 2014-02-27 4 AMAG AMAG PHARMACEUTICALS INC.
Stock Option (Right to Buy)
A - Award 18,800 18,800
2014-02-28 2014-02-27 4 AMAG AMAG PHARMACEUTICALS INC.
Common Stock
A - Award 3,100 14,696 26.73
2013-12-17 2013-12-16 4 AMAG AMAG PHARMACEUTICALS INC.
Common Stock
F - Taxes -654 11,596 -5.34 23.23 -15,192 269,375
2013-03-04 2013-02-28 4 AMAG AMAG PHARMACEUTICALS INC.
Stock Option (Right to Buy)
A - Award 15,000 15,000
2013-03-04 2013-02-28 4 AMAG AMAG PHARMACEUTICALS INC.
Common Stock
A - Award 5,000 7,500 200.00
2013-03-04 2013-02-28 4 AMAG AMAG PHARMACEUTICALS INC.
Common Stock
A - Award 2,500 2,500
2012-12-06 2012-12-05 4 AMAG AMAG PHARMACEUTICALS INC.
Restricted Stock Units
M - Exercise 2,500 2,500
2012-12-06 2012-12-05 4 AMAG AMAG PHARMACEUTICALS INC.
Common Stock
S - Sale X -2,500 0 -100.00 14.79 -36,975
2012-12-06 2012-12-05 4 AMAG AMAG PHARMACEUTICALS INC.
Common Stock
M - Exercise 2,500 2,500
2012-09-13 2012-09-12 4 AMAG AMAG PHARMACEUTICALS INC.
Restricted Stock Unit
C - Conversion 750 750
2012-09-13 2012-09-12 4 AMAG AMAG PHARMACEUTICALS INC.
Common Stock
S - Sale X -750 0 -100.00 15.54 -11,655
2012-09-13 2012-09-12 4 AMAG AMAG PHARMACEUTICALS INC.
Common Stock
C - Conversion 750 750
2012-06-27 2012-06-25 4 AMAG AMAG PHARMACEUTICALS INC.
Stock Options
A - Award 30,000 30,000
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)